Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1527-1535
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1527
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1527
Group | n | Lumbar spine (g/m2) | Hip joint (g/m2) | BALP (μg/mL) | P1NP (ng/mL) | BGP (μgmL) | β-CTX (ng/mL) |
Case group | 60 | 0.69 ± 0.08 | 0.66 ± 0.09 | 4.08 ± 1.20 | 49.16 ± 4.08 | 15.92 ± 4.08 | 0.49 ± 0.08 |
Control group | 60 | 0.95 ± 0.14 | 0.83 ± 0.10 | 4.03 ± 0.84 | 44.41 ± 2.75 | 14.40 ± 2.75 | 0.44 ± 0.08 |
Healthy group | 60 | 1.08 ± 0.16 | 0.99 ± 0.14 | 4.07 ± 0.82 | 31.59 ± 2.38 | 12.14 ± 2.38 | 0.41 ± 0.10 |
F | 142.637 | 130.422 | 0.036 | 122.211 | 21.822 | 14.496 | |
P value | 0.000 | 0.000 | 0.965 | 0.000 | 0.000 | 0.000 |
- Citation: Xie FF, Zhang YF, Hu YF, Xie YY, Wang XY, Wang SZ, Xie BQ. Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis. World J Clin Cases 2022; 10(5): 1527-1535
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1527.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1527